HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AB&B BIO-TECH-B

49.000

+1.0002.08%

Volume:322.00K

Turnover:15.79M

Market Cap:19.26B

PE:-69.01

High:49.500

Open:48.000

Low:48.000

Close:48.000

52wk High:59.600

52wk Low:33.000

Shares:393.00M

HK Float Shares:296.36M

Volume Ratio:1.51

T/O Rate:0.11%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.710

ROE:--

ROA:--

PB:505.73

PE(LYR):-69.01

PS:52.58

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Ab&B Bio-Tech (02627) Publishes Monthly Return for January 2026

Bulletin Express

AB&B BIO-TECH-B (02627): NMPA Approves Market Application for Trivalent Influenza Virus Subunit Vaccine

Ab&B Bio Tech Co Ltd Js - Approval of Application for Trivalent Subunit- Influenza Vaccine by Nmpa

THOMSON REUTERS

AB&B Bio-Tech Receives NMPA Approval for Trivalent Subunit Influenza Vaccine

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02627"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02627","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"AB&B BIO-TECH-B","latestPrice":49,"timestamp":1770710952786,"preClose":48,"halted":0,"volume":322000,"delay":0,"changeRate":0.020833333333333332,"floatShares":296361845,"shares":393000000,"eps":-0.71,"marketStatus":"Closed","change":1,"latestTime":"02-10 16:09:12","open":48,"high":49.5,"low":48,"amount":15791040,"amplitude":0.03125,"askPrice":49,"askSize":1200,"bidPrice":48.74,"bidSize":5800,"shortable":0,"etf":0,"ttmEps":-0.625,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":5,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":48,"openAndCloseTimeList":[[1770687000000,1770696000000],[1770699600000,1770710400000]],"volumeRatio":1.510602,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","floatShares":296361845,"roa":"--","roe":"--","lyrEps":-0.71,"volumeRatio":1.510602,"shares":393000000,"dividePrice":0,"high":49.5,"amplitude":0.03125,"preClose":48,"low":48,"week52Low":33,"pbRate":"505.73","psRate":"52.58","week52High":59.6,"institutionHeld":0,"latestPrice":49,"committee":0.657143,"eps":-0.71,"divideRate":0,"volume":322000,"delay":0,"ttmEps":-0.625,"open":48,"prevYearClose":40.24,"prevWeekClose":46.68,"prevMonthClose":48.5,"prevQuarterClose":40.24,"fiveDayClose":47,"twentyDayClose":42,"sixtyDayClose":40.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02627\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02627\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02627\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02627\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02627","date":"2026-02-09","current":-78.848,"percent":0.24,"low":-83.59026,"twenty":-75.685884,"median":-65.695031,"eighty":-64.128296,"high":-18.07815,"avg":-68.122435,"sd":8.08112,"marketCap":18885244800},"quantilePoints":[{"date":"2025-08-08","current":-18.07815,"twenty":-18.07815,"median":-18.07815,"eighty":-18.07815,"marketCap":5586884920},{"date":"2025-08-15","current":-60.155426,"twenty":-60.155426,"median":-56.438909,"eighty":-42.414982,"marketCap":18562621868},{"date":"2025-08-22","current":-65.870069,"twenty":-65.897052,"median":-63.746879,"eighty":-55.654938,"marketCap":20262293900},{"date":"2025-08-29","current":-64.920623,"twenty":-66.830053,"median":-65.395346,"eighty":-57.22288,"marketCap":20065572600},{"date":"2025-09-05","current":-62.716917,"twenty":-66.416243,"median":-63.912829,"eighty":-60.155426,"marketCap":19365244772},{"date":"2025-09-12","current":-62.655098,"twenty":-66.251138,"median":-63.08644,"eighty":-59.27469,"marketCap":19380982476},{"date":"2025-09-19","current":-81.048551,"twenty":-68.315951,"median":-63.912829,"eighty":-59.882299,"marketCap":19888523430},{"date":"2025-09-26","current":-77.095946,"twenty":-77.153546,"median":-65.395346,"eighty":-60.155426,"marketCap":18869507096},{"date":"2025-10-03","current":-76.784092,"twenty":-77.86406,"median":-66.074095,"eighty":-61.128611,"marketCap":18838031688},{"date":"2025-10-10","current":-75.450727,"twenty":-78.338288,"median":-66.623148,"eighty":-61.710077,"marketCap":18483933348},{"date":"2025-10-17","current":-70.044793,"twenty":-77.841467,"median":-68.315951,"eighty":-62.332762,"marketCap":17146228508},{"date":"2025-10-24","current":-70.694139,"twenty":-77.356453,"median":-69.86748,"eighty":-62.632094,"marketCap":17311474400},{"date":"2025-10-31","current":-64.652972,"twenty":-77.130506,"median":-68.586563,"eighty":-62.679826,"marketCap":15855736780},{"date":"2025-11-07","current":-65.014442,"twenty":-77.0495,"median":-67.012733,"eighty":-63.012535,"marketCap":15934425300},{"date":"2025-11-14","current":-69.152784,"twenty":-76.901535,"median":-66.692171,"eighty":-63.572329,"marketCap":16996720320},{"date":"2025-11-21","current":-64.47659,"twenty":-76.671062,"median":-66.251138,"eighty":-63.813259,"marketCap":15839999076},{"date":"2025-11-28","current":-66.221916,"twenty":-76.081201,"median":-65.883561,"eighty":-63.948664,"marketCap":16327867900},{"date":"2025-12-05","current":-64.387851,"twenty":-75.140133,"median":-65.711289,"eighty":-64.052768,"marketCap":15902949892},{"date":"2025-12-12","current":-65.09579,"twenty":-74.230454,"median":-65.51992,"eighty":-64.060512,"marketCap":16107540044},{"date":"2025-12-19","current":-64.75238,"twenty":-73.314016,"median":-65.09579,"eighty":-64.128623,"marketCap":16060326932},{"date":"2025-12-24","current":-63.88714,"twenty":-72.937878,"median":-65.019631,"eighty":-64.128296,"marketCap":15895081040},{"date":"2026-01-02","current":-63.38466,"twenty":-72.68164,"median":-64.955716,"eighty":-63.907691,"marketCap":15832130224},{"date":"2026-01-09","current":-64.42138,"twenty":-72.421694,"median":-64.920623,"eighty":-63.984499,"marketCap":16131146600},{"date":"2026-01-16","current":-79.012958,"twenty":-72.68164,"median":-65.002626,"eighty":-63.984499,"marketCap":19849179170},{"date":"2026-01-23","current":-80.264585,"twenty":-74.684429,"median":-65.09579,"eighty":-64.012742,"marketCap":20144261120},{"date":"2026-01-30","current":-75.685884,"twenty":-76.499114,"median":-65.441715,"eighty":-64.034272,"marketCap":19081966100},{"date":"2026-02-06","current":-72.661412,"twenty":-75.84841,"median":-65.678772,"eighty":-64.110439,"marketCap":18365900568},{"date":"2026-02-09","current":-74.55192,"twenty":-75.685884,"median":-65.695031,"eighty":-64.128296,"marketCap":18885244800}],"updateTime":1770690560805},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02627\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1136562498","title":"Ab&B Bio-Tech (02627) Publishes Monthly Return for January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1136562498","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136562498?lang=en_us&edition=fundamental","pubTime":"2026-02-03 17:08","pubTimestamp":1770109736,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech CO., LTD. JS (stock code: 02627) has released its monthly return for the period ended 31 January 2026. According to the announcement, the company’s total authorized share capital...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":0},{"id":"1187585697","title":"AB&B BIO-TECH-B (02627): NMPA Approves Market Application for Trivalent Influenza Virus Subunit Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1187585697","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187585697?lang=en_us&edition=fundamental","pubTime":"2026-01-30 17:04","pubTimestamp":1769763873,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) announced that the National Medical Products Administration (NMPA) of China has approved the new drug application for the Group's trivalent influenza virus subunit vaccine...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159646","02627"],"gpt_icon":0},{"id":"2607090775","title":"Ab&B Bio Tech Co Ltd Js - Approval of Application for Trivalent Subunit- Influenza Vaccine by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2607090775","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607090775?lang=en_us&edition=fundamental","pubTime":"2026-01-30 16:53","pubTimestamp":1769763224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nFWN3YV01K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2607809077","title":"AB&B Bio-Tech Receives NMPA Approval for Trivalent Subunit Influenza Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2607809077","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607809077?lang=en_us&edition=fundamental","pubTime":"2026-01-30 16:53","pubTimestamp":1769763211,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech Co. Ltd. JS announced that its new drug application for a trivalent subunit influenza vaccine has been approved by the National Medical Products Administration  of China. This vaccine is the first and only trivalent subunit influenza vaccine approved in China for all age groups at full dosage level as of the date of the announcement. The company states that this product offers comprehensive protection, high antigen purity, and low risks of adverse reactions compared to traditional split-virion vaccines. The announcement notes that there is no assurance the company will ultimately be able to develop and market the vaccine for all intended age groups successfully.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL2tQXTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02627\",params:#limit:6,delay:false,,,undefined,":[]}}